Terumo and Corazon sign collaboration and co-marketing agreement

February 28, 2022 – Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing agreement with Corazon, Inc., a leader in providing consulting, recruitment, interim management and accreditation services for heart, vascular, neuroscience and orthopedic specialty programs. 

Terumo Health Outcomes’ platform, ePRISM®, employs complex algorithms to predict – on an individual basis – patients who may have an unanticipated outcome following a cardiac procedure. Armed with this knowledge, clinicians can make informed treatment decisions pre-procedure that prevent complications and lead to better outcomes. In turn, Corazon’s unique E3® approach to accreditation allows customers to realize better quality cardiac care programs based on precision medicine. 

Terumo and Corazon share a common mission to improve patient care through innovation and expertise.  In bringing both solutions to customers this partnership creates synergies around excellence in processes of care, financial performance and most importantly, patient outcomes. 

Learn More 

safe online pharmacy for viagra cheap kamagra oral jelly online